Key Takeaways
- US Consumer Confidence slumped to 91.2 in June, significantly missing the estimate of 94.4 and falling from May's 93.1 as the Present Situation index weakened.
- JOLTS Job Openings rose to 7.594 million in May, surpassing expectations of 7.296 million and suggesting a labor market that remains tighter than anticipated.
- Bank of America issued a "Three-Wave Correction" warning, citing stretched valuations and fading liquidity as potential catalysts for a period of high volatility.
- Lockheed Martin (LMT) faces scrutiny after a GAO report suggested Pentagon staffing cuts to the weapons testing office could weaken critical defense oversight.
- Pharmaceutical giants Pfizer (PFE), Eli Lilly (LLY), and Bristol Myers Squibb (BMY) are under investigation by a US House Committee regarding drug trials conducted in China.
The US economy presented a complex picture on Tuesday as conflicting data points hit the wires. Consumer Confidence for June dropped to 91.2, missing the consensus estimate of 94.4. The Present Situation Index also saw a notable decline to 116.4 from 121.2, indicating that households are becoming increasingly concerned about current economic conditions.
In contrast, the labor market showed unexpected resilience. The May JOLTS Job Openings report showed 7.594 million vacancies, well above the 7.296 million forecast. While the Quits Rate remained steady at 1.9%, the higher-than-expected opening numbers suggest that labor demand is not cooling as quickly as the Federal Reserve might prefer to see in its fight against inflation.
Wall Street opened the session with a cautious tone. The Dow Jones Industrial Average edged up 65.30 points (0.13%), while the S&P 500 and Nasdaq both hovered near the flatline with slight losses. This tepid performance comes as Bank of America (BAC) analysts warned that a "three-wave correction" may be underway for global equities, driven by macroeconomic risks and fading liquidity support.
In the defense sector, Lockheed Martin (LMT) shares were pressured by a Government Accountability Office (GAO) report. The watchdog warned that staffing cuts at the Pentagon's weapons testing office, initiated by Defense Secretary Pete Hegseth, could weaken independent oversight. This raises concerns that major defense systems may face less rigorous testing before deployment.
The healthcare sector is also facing regulatory headwinds. A US House Committee has sent letters to Pfizer (PFE), Eli Lilly (LLY), and Bristol Myers Squibb (BMY) probing their drug trial activities in China. Pfizer has already confirmed receipt of the letter, as lawmakers seek more transparency regarding the safety and ethics of overseas clinical trials.
Geopolitical developments added to the day's uncertainty. Oman has reportedly proposed a shipping fee plan for the Strait of Hormuz to the US and its allies, according to the New York Times. Meanwhile, energy markets are monitoring supply shifts as Edison announced that Qatar has extended its LNG force majeure until early September, potentially tightening global gas supplies.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.